[Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
D000109:Acetylcholine / Q000032:analysis; D000818:Animals; D001480:Basal Ganglia Diseases; D001923:Brain Chemistry; D003342:Corpus Striatum / Q000032:analysis / Q000033:anatomy & histology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004298:Dopamine / Q000032:analysis / Q000502:physiology; D005116:Extrapyramidal Tracts; D005917:Globus Pallidus / Q000032:analysis / Q000033:anatomy & histology; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D010648:Phenylacetates / Q000378:metabolism; D010661:Phenylketonurias; D013378:Substantia Nigra / Q000032:analysis / Q000033:anatomy & histology / Q000473:pathology; D009435:Synaptic Transmission
D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D000109:Acetylcholine; D004298:Dopamine
Dofaminergicheskaia kontseptsiia parkinsonzma i lechenie ego L-DOF.